Fingolimod
- OralFingolimodGilenya
Mechanism of Action
- Inhibits the release of T cells from lymph nodes, resulting in redistribution of T cells and decreased entry into the central nervous system.
Clinical Use
- Indications
- Relapsing-remitting multiple sclerosis
- Secondary progressive multiple sclerosis
- Contraindications
- Other immunomodulatory agents
- Immunocompromised patients
- Adverse Effects
- Headache
- Elevated LFTs
- Diarrhoea
- Upper respiratory tract infection